CDXS also makes the intermediates for Incivek, Lipitor, and Januvia; however, CDXS's profit margin on sales of intermediates to pharma companies is paper thin.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.